Lara Lacerda

5.5k total citations · 1 hit paper
38 papers, 3.0k citations indexed

About

Lara Lacerda is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Lara Lacerda has authored 38 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Materials Chemistry and 14 papers in Oncology. Recurrent topics in Lara Lacerda's work include Carbon Nanotubes in Composites (12 papers), Graphene and Nanomaterials Applications (9 papers) and Cancer Cells and Metastasis (8 papers). Lara Lacerda is often cited by papers focused on Carbon Nanotubes in Composites (12 papers), Graphene and Nanomaterials Applications (9 papers) and Cancer Cells and Metastasis (8 papers). Lara Lacerda collaborates with scholars based in United States, United Kingdom and Italy. Lara Lacerda's co-authors include Kostas Kostarelos, Maurizio Prato, Alberto Bianco, Giorgia Pastorin, Ravi Singh, Cédric Klumpp, Davide Pantarotto, M. Antonia Herrero, Wendy A. Woodward and Khuloud T. Al‐Jamal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Lara Lacerda

37 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers

2006 788 citations Ravi Singh, Davide Pantarotto et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Lacerda United States	26	1.4k	1.4k	865	541	475	38	3.0k
Qizhen Cao United States	24	1.4k 1.0×	1.1k 0.8×	1.2k 1.4×	574 1.1×	720 1.5×	32	3.6k
Hongguang Liu United States	36	1.4k 1.0×	705 0.5×	990 1.1×	565 1.0×	304 0.6×	92	3.3k
Jiyou Han South Korea	29	1.4k 1.0×	841 0.6×	1.0k 1.2×	271 0.5×	429 0.9×	58	2.8k
Emily B. Ehlerding United States	33	1.7k 1.2×	1.0k 0.8×	969 1.1×	763 1.4×	861 1.8×	58	3.8k
Yoshinori Koyama Japan	31	1.2k 0.8×	811 0.6×	1.4k 1.6×	342 0.6×	334 0.7×	76	3.4k
Zhide Guo China	26	1.2k 0.8×	600 0.4×	735 0.8×	787 1.5×	398 0.8×	99	2.8k
Chenggen Qian China	32	2.1k 1.5×	1.1k 0.8×	1.1k 1.3×	257 0.5×	1.0k 2.1×	54	3.6k
Chunhui Wu China	36	1.7k 1.3×	789 0.6×	1.4k 1.6×	562 1.0×	994 2.1×	113	3.8k
Yiye Li China	30	2.3k 1.7×	1.6k 1.2×	1.4k 1.6×	506 0.9×	1.3k 2.6×	50	4.3k
Zhan Zhang Macao	21	1.8k 1.3×	690 0.5×	783 0.9×	291 0.5×	544 1.1×	38	2.7k

Countries citing papers authored by Lara Lacerda

Since Specialization

Citations

This map shows the geographic impact of Lara Lacerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Lacerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Lacerda more than expected).

Fields of papers citing papers by Lara Lacerda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Lacerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Lacerda. The network helps show where Lara Lacerda may publish in the future.

Co-authorship network of co-authors of Lara Lacerda

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Lacerda. A scholar is included among the top collaborators of Lara Lacerda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Lacerda. Lara Lacerda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elamin, Yasir Y., Daniel R. Gomez, Mara B. Antonoff, et al.. (2018). Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC). Clinical Lung Cancer. 20(1). 43–47. 44 indexed citations

Schvartsman, Gustavo, S. Andrew Peng, J. Jack Lee, et al.. (2017). Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer. 112. 90–95. 161 indexed citations

Schvartsman, Gustavo, S. Andrew Peng, J. Jack Lee, et al.. (2017). Response to single-agent (SA) chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 9083–9083. 2 indexed citations

Cáceres, Sara, L. Peña, Lara Lacerda, et al.. (2016). Canine cell line, IPC‐366, as a good model for the study of inflammatory breast cancer. Veterinary and Comparative Oncology. 15(3). 980–995. 10 indexed citations

Lacerda, Lara, Bisrat G. Debeb, Daniel L. Smith, et al.. (2015). Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Research. 17(1). 42–42. 45 indexed citations

Wolfe, Adam R., Bisrat G. Debeb, Lara Lacerda, et al.. (2015). Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Research and Treatment. 154(3). 495–508. 51 indexed citations

Debeb, Bisrat G., Lara Lacerda, Richard Larson, et al.. (2013). Abstract 3051: The miR-200 family as a potential therapeutic target in inflammatory breast cancer.. Cancer Research. 73(8_Supplement). 3051–3051. 1 indexed citations

Lacerda, Lara, Hanene Ali‐Boucetta, Sebastian Kraszewski, et al.. (2013). How do functionalized carbon nanotubes land on, bind to and pierce through model and plasma membranes. Nanoscale. 5(21). 10242–10242. 56 indexed citations

Xu, Wei, Lara Lacerda, Bisrat G. Debeb, et al.. (2013). The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer. PLoS ONE. 8(8). e71508–e71508. 42 indexed citations

10.

Lacerda, Lara, Julie Russier, Giorgia Pastorin, et al.. (2012). Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials. 33(11). 3334–3343. 193 indexed citations

11.

Debeb, Bisrat G., Lara Lacerda, Wei Xu, et al.. (2012). Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β‐Catenin Signaling. Stem Cells. 30(11). 2366–2377. 98 indexed citations

12.

Debeb, Bisrat G., Xiaomei Zhang, Savitri Krishnamurthy, et al.. (2010). Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular Cancer. 9(1). 180–180. 62 indexed citations

13.

Lacerda, Lara, Lajos Pusztai, & Wendy A. Woodward. (2010). The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches. Drug Resistance Updates. 13(4-5). 99–108. 66 indexed citations

14.

Klopp, Ann H., Lara Lacerda, Anshul Gupta, et al.. (2010). Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells. PLoS ONE. 5(8). e12180–e12180. 134 indexed citations

15.

Lacerda, Lara, Maurizio Prato, Alberto Bianco, & Kostas Kostarelos. (2008). Improved tissue distribution, renal clearance and toxicity profile of functionalized carbon nanotubes. UCL Discovery (University College London). 2(2008). 509–511. 1 indexed citations

16.

Lacerda, Lara, M. Antonia Herrero, Kerrie Venner, et al.. (2008). Carbon‐Nanotube Shape and Individualization Critical for Renal Excretion. Small. 4(8). 1130–1132. 144 indexed citations

17.

Kostarelos, Kostas, et al.. (2007). Cell-penetrating carbon nanotubes for delivery of therapeutics. Nano Today. 2(6). 38–43. 12 indexed citations

18.

Klumpp, Cédric, Lara Lacerda, Olivier Chaloin, et al.. (2007). Multifunctionalised cationic fullerene adducts for gene transfer: design, synthesis and DNA complexation. Chemical Communications. 3762–3762. 44 indexed citations

19.

Lacerda, Lara, Giorgia Pastorin, J. R. Buddle, et al.. (2007). Intracellular Trafficking of Carbon Nanotubes by Confocal Laser Scanning Microscopy. Advanced Materials. 19(11). 1480–1484. 58 indexed citations

20.

Singh, Ravi, Davide Pantarotto, Lara Lacerda, et al.. (2006). Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proceedings of the National Academy of Sciences. 103(9). 3357–3362. 788 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact